» Articles » PMID: 21084494

A Standardized Comparison of Commercially Available Prion Decontamination Reagents Using the Standard Steel-Binding Assay

Overview
Journal J Gen Virol
Specialty Microbiology
Date 2010 Nov 19
PMID 21084494
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Prions are comprised principally of aggregates of a misfolded host protein and cause fatal transmissible neurodegenerative disorders of mammals, such as variant Creutzfeldt-Jakob disease in humans and bovine spongiform encephalopathy in cattle. Prions pose significant public health concerns through contamination of blood products and surgical instruments, and can resist conventional hospital sterilization methods. Prion infectivity binds avidly to surgical steel and can efficiently transfer infectivity to a suitable host, and much research has been performed to achieve effective prion decontamination of metal surfaces. Here, we exploit the highly sensitive Standard Steel-Binding Assay (SSBA) to perform a direct comparison of a variety of commercially available decontamination reagents marketed for the removal of prions, alongside conventional sterilization methods. We demonstrate that the efficacy of marketed prion decontamination reagents is highly variable and that the SSBA is able to rapidly evaluate current and future decontamination reagents.

Citing Articles

Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimetic.

Heinzer D, Avar M, Pfammatter M, Moos R, Schwarz P, Buhmann M PLoS One. 2024; 19(6):e0304603.

PMID: 38870196 PMC: 11175539. DOI: 10.1371/journal.pone.0304603.


Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments.

Moudjou M, Castille J, Passet B, Herzog L, Reine F, Vilotte J Front Bioeng Biotechnol. 2020; 8:591024.

PMID: 33335894 PMC: 7736614. DOI: 10.3389/fbioe.2020.591024.


A Novel, Reliable and Highly Versatile Method to Evaluate Different Prion Decontamination Procedures.

Erana H, Perez-Castro M, Garcia-Martinez S, Charco J, Lopez-Moreno R, Diaz-Dominguez C Front Bioeng Biotechnol. 2020; 8:589182.

PMID: 33195153 PMC: 7658626. DOI: 10.3389/fbioe.2020.589182.


Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Stevenson M, Uttley L, Oakley J, Carroll C, Chick S, Wong R Health Technol Assess. 2020; 24(11):1-150.

PMID: 32122460 PMC: 7103914. DOI: 10.3310/hta24110.


Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery.

Jaunmuktane Z, Quaegebeur A, Taipa R, Viana-Baptista M, Barbosa R, Koriath C Acta Neuropathol. 2018; 135(5):671-679.

PMID: 29450646 PMC: 5904220. DOI: 10.1007/s00401-018-1822-2.


References
1.
Cronier S, Gros N, Tattum M, Jackson G, Clarke A, Collinge J . Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J. 2008; 416(2):297-305. PMC: 2584334. DOI: 10.1042/BJ20081235. View

2.
Edgeworth J, Jackson G, Clarke A, Weissmann C, Collinge J . Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces. Proc Natl Acad Sci U S A. 2009; 106(9):3479-83. PMC: 2637901. DOI: 10.1073/pnas.0813342106. View

3.
Collinge J . Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001; 24:519-50. DOI: 10.1146/annurev.neuro.24.1.519. View

4.
Joiner S, Linehan J, Brandner S, Wadsworth J, Collinge J . Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2002; 73(5):597-8. PMC: 1738116. DOI: 10.1136/jnnp.73.5.597. View

5.
Klohn P, Stoltze L, Flechsig E, Enari M, Weissmann C . A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci U S A. 2003; 100(20):11666-71. PMC: 208815. DOI: 10.1073/pnas.1834432100. View